Advanced Search

 

Study ID Status Title Patient Level Data
112626 Completed A Multi-Center, Open-Label, Continuation Trial LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Systemic Lupus Erythematosus (SLE) who Completed the Phase 2 Protocol LBSL02
112630 Completed Non-steroidal anti-inflammatory drugs alone or with a triptan and reports of transition from episodic to chronic migraine
112640 Completed Immunogenicity, safety and reactogenicity of GlaxoSmithKline Biologicals’ pneumococcal vaccine GSK1024850A following primary and booster vaccination of healthy Japanese children Study Listed on ClinicalStudyDataRequest.com
112646 Completed Outcomes and Costs Associated with initiating Maintenance Treatment with Fluticasone Propionate 250mcg/Salmeterol xinafoate 50mcg Combination (FSC) Versus Anticholinergics including Tiotropium (TIO) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
112648 Completed An open-label, randomized, single sequence, two period study to assess the effect of repeat oral dosing of ketoconazole on the pharmacokinetics of a single oral dose of GSK962040 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
112657 Completed A double-blind, randomized, placebo controlled, dose escalation, multi-centerphase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20antibody, in patients with active rheumatoid arthritis who have previously failedone or more disease modifying anti-rheumatic drugs
112657_1 Completed A double-blind, randomized, placebo-controlled, dose escalation, multi-center phase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody in subjects with active rheumatoid arthritis who have previously failed one or iore disease modifying
112657_2 Completed A double-blind, randomized, placebo-controlled, dose escalation, multi-center phase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody in subjects with active rheumatoid arthritis who have previously failed one or iore disease modifying
112657_3 Completed A double-blind, randomized, placebo-controlled, dose escalation, multi-center phase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody in subjects with active rheumatoid arthritis who have previously failed one or iore disease modifying
112662 Completed Immunogenicity and safety study of GSK Biologicals’ influenza vaccine GSK2186877A in elderly adults. Study Listed on ClinicalStudyDataRequest.com
112668 Completed A Double-Blind, Parallel, Randomized, Placebo-Controlled, Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
112670 Completed A multi-center, placebo-controlled study to evaluate the safety of GSK716155 and its effects on myocardial metabolism, myocardial function, and exercise capacity in patients with NYHA Class II/III congestive heart failure Study Listed on ClinicalStudyDataRequest.com
112673 Completed Safety and immunogenicity of GlaxoSmithKline Biologicals’ herpes zoster vaccine 1437173A in adult HIV-infected subjects Study Listed on ClinicalStudyDataRequest.com
112676 Terminated Double blind, double-dummy, randomised, placebo controlled study to evaluate the effect of single doses of drug A (lamotrigine) and drug B (vofopitant) alone and in combination on resting motor threshold in healthy subjects Study Listed on ClinicalStudyDataRequest.com
112677 Completed Cervarix long-term safety surveillance using the PGRx information system (PGRx study)
112679 Completed Immunogenicity and safety of GSK Biologicals’ IPV (Poliorix™) in infants Study Listed on ClinicalStudyDataRequest.com
112679 Completed Immunogenicity and safety of GSK Biologicals’ IPV (Poliorix™) in infants Study Listed on ClinicalStudyDataRequest.com
112680 Completed A Phase I, Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of the BRAF Inhibitor GSK2118436 in Subjects with Solid Tumors
112682 Completed Long-term persistence of hepatitis B antibodies and immune response to a hepatitis B vaccine challenge in 12-13 year old adolescents, vaccinated in infancy with GlaxoSmithKline (GSK) Biologicals’ HBV vaccine (Engerix™-B) Study Listed on ClinicalStudyDataRequest.com
112683 Completed An open-label study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ Inactivated Poliomyelitis Vaccine Poliorix administered as a booster dose at 18-24 months of age in healthy toddlers in China. Study Listed on ClinicalStudyDataRequest.com
112684 Completed Validation Study of Simultaneous Administration of Multiple Cytochrome P450/Transporter Probes for Drug Interaction Evaluation in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
112688 Completed Long-term antibody persistence of hepatitis B antibodies and immune response to a hepatitis B vaccine (Engerix-B Kinder) challenge in children previously vaccinated with Infanrix hexa vaccine Study Listed on ClinicalStudyDataRequest.com
112689 Completed A Phase I, Open-Label, Two-Stage Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Oral AKT Inhibitor GSK2141795 in Subjects with Solid Tumors or Lymphomas
112690 Completed A bioequivalence study comparing Zantac 150mg (coated with Opadry White OY-S-7332) to Zantac 150mg (coated with Opaspray White K-1R-7000)
112691 Completed Immunogenicity and safety study of GSK Biologicals’ monovalent pandemic H5N1 vaccine 1557484A in adults aged 18 – 64 years Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.